154 related articles for article (PubMed ID: 30722017)
1. Population Pharmacokinetics of Intravenous Colistin in Pediatric Patients: Implications for the Selection of Dosage Regimens.
Ooi MH; Ngu SJ; Chor YK; Li J; Landersdorfer CB; Nation RL
Clin Infect Dis; 2019 Nov; 69(11):1962-1968. PubMed ID: 30722017
[TBL] [Abstract][Full Text] [Related]
2. Dosing guidance for intravenous colistin in critically-ill patients.
Nation RL; Garonzik SM; Thamlikitkul V; Giamarellos-Bourboulis EJ; Forrest A; Paterson DL; Li J; Silveira FP
Clin Infect Dis; 2017 Mar; 64(5):565-571. PubMed ID: 28011614
[TBL] [Abstract][Full Text] [Related]
3. Updated US and European Dose Recommendations for Intravenous Colistin: How Do They Perform?
Nation RL; Garonzik SM; Li J; Thamlikitkul V; Giamarellos-Bourboulis EJ; Paterson DL; Turnidge JD; Forrest A; Silveira FP
Clin Infect Dis; 2016 Mar; 62(5):552-558. PubMed ID: 26607424
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of colistin in critically ill patients with multidrug-resistant Gram-negative bacilli infection.
Karnik ND; Sridharan K; Jadhav SP; Kadam PP; Naidu RK; Namjoshi RD; Gupta V; Gore MS; Surase PV; Mehta PR; Gogtay JA; Thatte UM; Gogtay NJ
Eur J Clin Pharmacol; 2013 Jul; 69(7):1429-36. PubMed ID: 23508665
[TBL] [Abstract][Full Text] [Related]
5. Dose recommendations for intravenous colistin in pediatric patients from a prospective, multicenter, population pharmacokinetic study.
Wacharachaisurapol N; Sukkummee W; Anunsittichai O; Srisan P; Sangkhamal S; Chantharit P; Vandepitte WP; Wattanavijitkul T; Puthanakit T
Int J Infect Dis; 2021 Aug; 109():230-237. PubMed ID: 34192578
[TBL] [Abstract][Full Text] [Related]
6. Population Pharmacokinetics and Outcomes of Critically Ill Pediatric Patients Treated with Intravenous Colistin at Higher Than Recommended Doses.
Antachopoulos C; Geladari A; Landersdorfer CB; Volakli E; Ilia S; Gikas E; Gika H; Sdougka M; Nation RL; Roilides E
Antimicrob Agents Chemother; 2021 May; 65(6):. PubMed ID: 33782000
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of Colistin Following a Single Dose of Intravenous Colistimethate Sodium in Critically Ill Neonates.
Nakwan N; Usaha S; Chokephaibulkit K; Villani P; Regazzi M; Imberti R
Pediatr Infect Dis J; 2016 Nov; 35(11):1211-1214. PubMed ID: 27276179
[TBL] [Abstract][Full Text] [Related]
8. Colistin Use in Patients with Chronic Kidney Disease: Are We Underdosing Patients?
Sorli L; Luque S; Li J; Rodríguez E; Campillo N; Fernandez X; Soldado J; Domingo I; Montero M; Grau S; Horcajada JP
Molecules; 2019 Feb; 24(3):. PubMed ID: 30717123
[TBL] [Abstract][Full Text] [Related]
9. Greater optimisation of pharmacokinetic/pharmacodynamic parameters through a loading dose of intravenous colistin in paediatric patients.
Wacharachaisurapol N; Phasomsap C; Sukkummee W; Phaisal W; Chanakul A; Wittayalertpanya S; Chariyavilaskul P; Puthanakit T
Int J Antimicrob Agents; 2020 Jun; 55(6):105940. PubMed ID: 32179149
[TBL] [Abstract][Full Text] [Related]
10. Differences in pharmacokinetics and pharmacodynamics of colistimethate sodium (CMS) and colistin between three different CMS dosage regimens in a critically ill patient infected by a multidrug-resistant Acinetobacter baumannii.
Luque S; Grau S; Valle M; Sorlí L; Horcajada JP; Segura C; Alvarez-Lerma F
Int J Antimicrob Agents; 2013 Aug; 42(2):178-81. PubMed ID: 23769664
[TBL] [Abstract][Full Text] [Related]
11. Clinical efficacy and pharmacokinetics of colistimethate sodium and colistin in critically ill patients in an Indian hospital with high endemic rates of multidrug-resistant Gram-negative bacterial infections: A prospective observational study.
Moni M; Sudhir AS; Dipu TS; Mohamed Z; Prabhu BP; Edathadathil F; Balachandran S; Singh SK; Prasanna P; Menon VP; Patel T; Patel P; Kaye KS; Menon VP
Int J Infect Dis; 2020 Nov; 100():497-506. PubMed ID: 32781161
[TBL] [Abstract][Full Text] [Related]
12. Colistin Population Pharmacokinetics after Application of a Loading Dose of 9 MU Colistin Methanesulfonate in Critically Ill Patients.
Karaiskos I; Friberg LE; Pontikis K; Ioannidis K; Tsagkari V; Galani L; Kostakou E; Baziaka F; Paskalis C; Koutsoukou A; Giamarellou H
Antimicrob Agents Chemother; 2015 Dec; 59(12):7240-8. PubMed ID: 26369974
[TBL] [Abstract][Full Text] [Related]
13. Multicenter Population Pharmacokinetic Study of Colistimethate Sodium and Colistin Dosed as in Normal Renal Function in Patients on Continuous Renal Replacement Therapy.
Leuppi-Taegtmeyer AB; Decosterd L; Osthoff M; Mueller NJ; Buclin T; Corti N
Antimicrob Agents Chemother; 2019 Feb; 63(2):. PubMed ID: 30478168
[TBL] [Abstract][Full Text] [Related]
14. Substantial Targeting Advantage Achieved by Pulmonary Administration of Colistin Methanesulfonate in a Large-Animal Model.
Landersdorfer CB; Nguyen TH; Lieu LT; Nguyen G; Bischof RJ; Meeusen EN; Li J; Nation RL; McIntosh MP
Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27821445
[TBL] [Abstract][Full Text] [Related]
15. Impact of colistin plasma levels on the clinical outcome of patients with infections caused by extremely drug-resistant Pseudomonas aeruginosa.
Sorlí L; Luque S; Segura C; Campillo N; Montero M; Esteve E; Herrera S; Benito N; Alvarez-Lerma F; Grau S; Horcajada JP
BMC Infect Dis; 2017 Jan; 17(1):11. PubMed ID: 28056821
[TBL] [Abstract][Full Text] [Related]
16. Steady-state pharmacokinetic and pharmacodynamic profiling of colistin in critically ill patients with multi-drug-resistant gram-negative bacterial infections, along with differences in clinical, microbiological and safety outcome.
Ram K; Sheikh S; Bhati RK; Tripathi CD; Suri JC; Meshram GG
Basic Clin Pharmacol Toxicol; 2021 Jan; 128(1):128-140. PubMed ID: 33245629
[TBL] [Abstract][Full Text] [Related]
17. Population pharmacokinetic analysis of colistin in burn patients.
Lee J; Han S; Jeon S; Hong T; Song W; Woo H; Yim DS
Antimicrob Agents Chemother; 2013 May; 57(5):2141-6. PubMed ID: 23439640
[TBL] [Abstract][Full Text] [Related]
18. Systemic pharmacokinetics and safety of high doses of nebulized colistimethate sodium in critically ill patients with hospital-acquired and ventilator-associated pneumonia.
Benítez-Cano A; de Antonio-Cuscó M; Luque S; Sorlí L; Carazo J; Ramos I; Bermejo S; Campillo N; Horcajada JP; Samsó E; Grau S
J Antimicrob Chemother; 2019 Nov; 74(11):3268-3273. PubMed ID: 31495877
[TBL] [Abstract][Full Text] [Related]
19. Urinary Concentrations of Colistimethate and Formed Colistin after Intravenous Administration in Patients with Multidrug-Resistant Gram-Negative Bacterial Infections.
Luque S; Escaño C; Sorli L; Li J; Campillo N; Horcajada JP; Salas E; Grau S
Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28559275
[TBL] [Abstract][Full Text] [Related]
20. Population pharmacokinetics of colistin and the relation to survival in critically ill patients infected with colistin susceptible and carbapenem-resistant bacteria.
Kristoffersson AN; Rognås V; Brill MJE; Dishon-Benattar Y; Durante-Mangoni E; Daitch V; Skiada A; Lellouche J; Nutman A; Kotsaki A; Andini R; Eliakim-Raz N; Bitterman R; Antoniadou A; Karlsson MO; Theuretzbacher U; Leibovici L; Daikos GL; Mouton JW; Carmeli Y; Paul M; Friberg LE
Clin Microbiol Infect; 2020 Dec; 26(12):1644-1650. PubMed ID: 32213316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
